The CYP19A1 gene gives your body instructions to make aromatase, an enzyme that turns certain hormones into estrogen. This gene plays an important role in growth, puberty, bone strength, fertility, and how the ovaries, testes, and other tissues balance sex hormones. If the gene does not work properly, estrogen levels may be too low or too high, which can affect sexual development, menstrual periods, fertility, and bone health.
What is a gene?
Genes are sections of DNA that provide your cells with instructions for making molecules or directing processes in the body. Some genes hold the information needed to make proteins, the parts of cells that do the work. Other genes mostly regulate when certain processes happen, where they happen, and how strongly they run. Together, genes influence how the body develops and works, and they can shape how you respond to food, stress, and medications. You can find more on this topic in the LearnHub.
Overview
CYP19A1Gene function
What if the gene works
The CYP19A1 gene helps your body make estrogen by changing certain hormones into estrogens. This supports sexual development, menstrual cycles, bone health, and fertility.
Risk
What if the gene does not work
Variants in the CYP19A1 gene can reduce or increase estrogen production. Milder to more severe variants may lead to differences in sexual development, puberty, fertility, and bone strength, while increased activity can cause early puberty or excess breast growth.
Treatment
What does that mean for your treatment
Pathogenic variants in the CYP19A1 gene can make estrogen replacement a central part of treatment. In girls and women, this often helps support puberty, menstrual health, and bone strength. In boys and men, estrogen may also be used to support bone health and more typical bone maturation.
Conditions associated with CYP19A1
Gene function
What if the gene works
Your body uses the CYP19A1 gene to make aromatase, an enzyme that turns certain hormones into estrogen. This step is central to how the CYP19A1 gene helps make estrogen throughout the body. Aromatase is active in tissues such as the ovaries, testes, fat tissue, skin, brain, and placenta.
Its main job is to convert certain androgen hormones into estrogen. This gives the body a direct way to produce estrogens such as estradiol and estrone.
By changing one type of sex hormone into another, the CYP19A1 gene helps keep hormone signals balanced. This supports normal communication between tissues that respond to estrogen.
Many tissues can make estrogen close to where it is needed by using aromatase. This helps nearby cells respond to local hormone signals in a more controlled way.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP19A1 gene can lower, disrupt, or occasionally increase aromatase activity, changing how well cells convert androgens into estrogens. Some changes slightly reduce enzyme stability or efficiency, while more disruptive variants can markedly limit protein production or leave the enzyme unable to work. Understanding how variants in the CYP19A1 gene affect aromatase activity helps explain why effects may range from mild to more pronounced, and why symptom timing and severity can differ.
How variants are linked to conditions
Variants in the CYP19A1 gene are mainly linked to rare inherited conditions affecting sex development, growth, and hormone balance. Pathogenic variants in both copies of the CYP19A1 gene cause aromatase deficiency, while certain structural changes can cause aromatase excess syndrome. In practical terms, this is how CYP19A1 gene variants are linked to conditions that may affect puberty, fertility, and bone health.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific everyday factors that increase or reduce health risk related to CYP19A1 itself. Some health effects linked to CYP19A1 can vary with the exact gene change, hormone levels, age, and sex, so personal risk is best discussed with a doctor or genetic counselor.
Inheritance of CYP19A1 variants
How CYP19A1 gene variants are inherited depends on the specific CYP19A1-related condition. For aromatase deficiency, the usual pattern is autosomal recessive, which means a child inherits one variant from each parent and, if both parents are carriers, each pregnancy has a 25% chance of being affected. For aromatase excess syndrome, the pattern is autosomal dominant, so one altered copy can be enough and an affected parent can pass it on with a 50% chance in each pregnancy.
What does my CYP19A1 result mean for my family?
For family members, the meaning of a CYP19A1 result depends on which CYP19A1-related condition is involved. Some CYP19A1 changes are linked to a recessive condition, so parents, brothers, sisters, and children may be carriers or, less often, also be affected. Other CYP19A1 changes are linked to a dominant condition, which means close relatives may also carry the same change and could consider discussing family testing.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked to CYP19A1-related conditions, genetic testing for variants in the CYP19A1 gene uses a blood, saliva, or cheek swab sample. A lab reads the DNA sequence and checks for variants that may help confirm a diagnosis or explain a family pattern.
When should I consider getting a genetic test?
Consider testing for the CYP19A1 gene if there is a family history or a strong medical clue to a rare condition affecting estrogen production, such as unusual genital development at birth, delayed puberty, infertility, or a pregnant parent developing male-pattern body changes. Testing can help confirm whether a CYP19A1 change is the cause.
A genetic result is only one part of your health story
A genetic result can be informative, but what it can tell you varies depending on the condition and the kind of variant involved. How the body functions over time is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds at the drug’s target. This is common and can influence how well a treatment works or how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. More details on this topic are available in the LearnHub.
Drugs influenced by the CYP19A1 gene
When should I seek medical advice?
There is not yet a widely confirmed role for this gene in guiding medicine choices, so any concerns about side effects, how well a treatment is working, or medication changes are best discussed with your doctor. CYP19A1 has been studied in people taking hormone-blocking breast cancer medicines called aromatase inhibitors, but those findings are not strong enough to guide routine care.
History
Researchers linked the CYP19A1 gene to human health as studies of estrogen production advanced in the late 20th century. In recent decades, awareness of this gene’s role has grown. A major step came when scientists identified CYP19A1 as the gene that encodes aromatase, the enzyme that makes estrogen, helping explain rare inherited conditions with unusually low or high estrogen levels. That discovery also mattered for cancer care, because aromatase became an important target for hormone treatment in some breast cancers. From these first observations, research expanded steadily. Today, the history of the CYP19A1 gene is closely tied to progress in endocrinology, reproductive medicine, and hormone based cancer treatment.